Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor‐informed assay

BACKGROUND: Circulating tumor DNA (ctDNA)‐based minimal residual disease (MRD) detection, which can identify disease relapse ahead of radiological imaging, has shown promising performance. The objective of this study was to develop and validate OriMIRACLE S (Minimal Residual Circulating Nucleic Acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Zining, Li, Yi, Wang, ZhengKun, Tan, Xuerong, Zhou, Yixuan, Li, Zhendong, Zhao, Weirong, Zheng, Xin, Yao, Jicheng, Li, Feng, Wang, Weifeng, Wang, Zhizheng, Pang, Fei, Wang, Gang, Gu, Weiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501225/
https://www.ncbi.nlm.nih.gov/pubmed/37602656
http://dx.doi.org/10.1002/cam4.6286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501225/
https://www.ncbi.nlm.nih.gov/pubmed/37602656
http://dx.doi.org/10.1002/cam4.6286

Ejemplares similares